To investigate whether mutant IDH1 could enhance the susceptibility of glioma cells to VSVΔ51, we orthotopically transplanted GL261-TRE-IDH1(R132H) cells into immunocompetent mice (Fig. 6e). Here, IDH1 is linked to central nervous system cancer.